Liver transplantation for hepatocellular carcinoma
Mohannad F. Dugum, Nizar N. Zein – 26 February 2016
Liver transplantation for hepatocellular carcinoma
Mohannad F. Dugum, Nizar N. Zein – 26 February 2016
Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma
Pranab M. Barman, Grace L. Su – 26 February 2016
Limitations of the barcelona clinic liver cancer staging system with a focus on transarterial chemoembolization as a key modality for treatment of hepatocellular carcinoma
Pranab M. Barman, Grace L. Su – 26 February 2016
Assessing the risk of bleeding and clotting in cirrhosis
Neeral L. Shah, Stephen H. Caldwell – 26 February 2016
Reversal of acquired hepatocerebral degeneration with living donor liver transplantation
Shayon D. Salehi, Debbie L. Shawcross – 26 February 2016
Cannabinoids in liver diseases
Eleonora Patsenker, Felix Stickel – 26 February 2016
A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver disease
Jagpal Singh Klair, Ju Dong Yang, Manal F. Abdelmalek, Cynthia D. Guy, Ryan M. Gill, Katherine Yates, Aynur Unalp‐Arida, Joel E. Lavine, Jeanne M. Clark, Anna Mae Diehl, Ayako Suzuki, for the Nonalcoholic Steatohepatitis Clinical Research Network – 26 February 2016 – Postmenopausal women with nonalcoholic steatohepatitis are at an increased risk of hepatic fibrosis compared with premenopausal women. Whether duration of estrogen deficiency in postmenopausal state dictates an individual's fibrosis risk remains uninvestigated.
The hospital pager: Out with the old or here to stay?
Lisa M. McElroy, Elizabeth Z. Gillett, Cristina Nguyen, Jane L. Holl, Michael M. Abecassis, Daniela P. Ladner – 26 February 2016
Author Checklist
25 February 2016